Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer
04 mars 2024 08h00 HE
|
Osmol Therapeutics
Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer